A plastic shell on the chest may help older adults with obesity breathe easier
NCT ID NCT05028309
First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time
Summary
This study tests whether a device called an external cuirass, a plastic shell worn over the chest, can reduce the extra effort of breathing that often comes with obesity in older age. Researchers will compare older adults with and without obesity, aged 65 to 75, measuring lung function, exercise tolerance, and breathlessness at rest and during cycling. Some participants will use the cuirass to gently unload the chest wall, and the team will see if that improves breathing and comfort.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- External cuirass, a plastic shell worn over the chest that applies gentle pressure to help with breathing
- What this could lead to
- If it works, this could point toward a non-drug way to help older adults with obesity breathe easier and exercise more comfortably.
- What could go wrong
- This is an early, small study, so results may not apply to everyone. The chest shell may feel awkward or cause discomfort, and it is not yet known if it will meaningfully improve daily life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 72 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2021
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Otherwise healthy older adults 65-75 years of age with normal lung function; men 30\< %body fat ≤50 and women 35\< %body fat ≤55; and ability to perform pulmonary and exercise test. Other inclusion criteria include the following: * Nonsmokers who have no history of smoking * No personal history of significant mental illness * No weight loss dietary restrictions * No current or past history of significant substance or alcohol abuse * No history, evidence, or uncontrolled symptoms of heart disease * No history of uncontrolled hypertension * No current medications that may interfere with exercise capacity * No recent history or indication of asthma * No musculoskeletal abnormality that would preclude exercise * No serious health conditions that would preclude study goals or participation in exercise (per PI \& medical staff \& preliminary or follow up testing; including significant other diseases, occult asthma, prior surgeries-especial lung or abdominal, or history of chemotherapy that could affect lung or heart function) * Only postmenopausal women will be included. * Women on hormone replacement therapy will be allowed to participate if the dosage remains similar during the entire protocol. Exclusion Criteria: * Volunteers with a mMRC score of 3 or 4 will be excluded due to likeliness of underlying disease. * Individuals participating in regular vigorous conditioning exercise such as running, jogging, aerobics, cycling, or swimming more than three times per week will be excluded. However, if subjects have an exceedingly high exercise capacity (greater than 2 SD of predicted), they will be excluded. * Maximal cycle ergometry test will be used to determine if further participation in testing is appropriate for the participant (e.g., normal exercise test, exclude presence of provokable ECG changes suggestive of heart disease, or dangerous arrhythmias or exercise induced hypertension or bronchoconstriction. If the participant develops an abnormal ECG or shows other signs of exercise intolerance or if signs of cardiovascular disease are noted during the exercise test, it will be terminated and the participant will be referred to their personal physician for further evaluation (see DMSP). * Premenopausal women will be excluded.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Aging are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Institute for Exercise and Environmental Medicine, UT Southwestern and Texas Health Resources
RECRUITINGDallas, Texas, 75231, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The acute effects of an endurance exercise bout the gut microbiome and gut-derived metabolome in Women's distinct fitness and body mass indexes
- Pilot study to evaluate the effect of nicotinamide riboside on immune activation in psoriasis
- The feasibility of electrical impedance tomography to guide non-invasive respiratory interventions in chronic respiratory disease
- Skeletal muscle myosin binding protein c in fatigue and aging
- Longevity metrics AI/ML development study: a standing data library and Model-Development platform for predicting and validating health measurements, longevity, and disease
- Can a new injection help tackle obesity? a trial puts it to the test